MOS:NYSEMosaic Company (The) Analysis
Data as of 2026-08-30 - not real-time
$23.60
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The Mosaic Company trades at $23.60, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 6.6%. Momentum indicators put RSI at 55.4 (neutral) with MACD reading bullish. Price has been bracketed by support at $20.82 and resistance at $25.20.
The shares look undervalued at 14.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 12.2% above the current price. Revenue is contracting at 6.0% on a -5.2% profit margin. The 3.70% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 39.7%, a beta of 0.78 and a maximum drawdown of 44.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
The shares look undervalued at 14.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 12.2% above the current price. Revenue is contracting at 6.0% on a -5.2% profit margin. The 3.70% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 39.7%, a beta of 0.78 and a maximum drawdown of 44.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
Updated Jul 15, 2026 0 TAMPA, Fla., July 15, 2026 /PRNewswire/ -- The Mosaic Company NYSE: MOS plans to release second...Despite phosphate production cuts and elevated input costs, The Mosaic Co MOS leverages strong liquidity and cost...The Mosaic Company NYSE: MOS announced today that its Board of Directors declared a quarterly dividend of $0.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 24.53
- MACD momentum is positive
- 30-day price change of +6.6%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 3.70% looks stretched against payout coverage
- Trading below the 200-day average of 24.53
- Analyst targets imply +12.2% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 3.70% looks stretched against payout coverage
- Negative profit margin of -5.2%
- Analyst targets imply +12.2% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-6.00%
Profit Margin-5.21%
P/E Ratio14.7
ROE-5.07%
ROA1.24%
Debt/Equity52.25
P/B Ratio0.7
Op. Cash Flow$444.0M
Free Cash Flow$-746275008
Technical Analysis
TrendNeutral
RSI55.4
Support$20.82
Resistance$25.20
MA 20$22.96
MA 50$22.38
MA 200$24.53
MACDBullish
VolumeStable
Fear & Greed Index95.66
Valuation
Target Price$26.47
Upside/Downside12.15%
GradeUndervalued
TypeValue
Dividend Yield3.70%
Risk Assessment
Beta0.78
Volatility39.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.